Oppenheimer Upgrades Inspire Medical to Outperform with $85 Target After Q2 Beat
Company raises 2026 guidance and launches cost-cutting plan.
Already have an account? Sign in.
Company raises 2026 guidance and launches cost-cutting plan.
FDA warned Neogen after HYCOAT, sold as sterile, was tied to fungal infections and horse deaths. Nearly 100 cases; at least 20 euthanized.
SSTI shareholders are offered $8 plus up to $3 via a CVR as Transom takes the public-safety company private.
Oracle rose after OpenAI’s annualized revenue neared $70 billion. Enterprise AI demand is a key signal for Oracle’s compute backlog.